Tinaghanao, Addi .
HRN: 26-72-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/21/2025
02/28/2025
IV
1.5gms
Q8
Acute Tonsillopharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes